AI integration in healthcare drives need for new validation models

The integration of artificial intelligence into healthcare and life sciences is driving a shift toward non-deterministic models that require new validation frameworks. Traditional software validation relies on deterministic processes where specific inputs yield identical outputs, but AI and machine learning models evolve over time, making legacy static protocols insufficient for regulatory compliance with bodies like the FDA and EMA.

To address the “black box” challenge, regulated environments require explainable, traceable, and reversible AI logic. Current Computer System Validation (CSV) frameworks can increase project costs by at least 30 percent due to blanket testing. Experts suggest that for AI to be GxP compliant, validation must become a continuous process integrated into DevOps pipelines.

In a related development in precision medicine, PGxAI has announced that its Andromeda clinical decision-support platform is now a Qualified Solution on the Mayo Clinic Platform. Andromeda integrates pharmacogenomics, multi-omics datasets, and real-world evidence into electronic health record workflows. The platform aims to reduce trial-and-error medicine by optimizing therapy selection and metabolic dosing while maintaining clinician oversight through an explainable AI architecture.